Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ProStrakan, Quintiles sales and marketing update

Quintiles' NovaQuest unit received rights to market PSK's Sancuso granisetron patch

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE